Biological predictors of survival in stage II colorectal cancer

  • Authors:
    • Yoshitake Ueda
    • Kazuhiro Yasuda
    • Masafumi Inomata
    • Norio Shiraishi
    • Shigeo Yokoyama
    • Seigo Kitano
  • View Affiliations

  • Published online on: May 20, 2013     https://doi.org/10.3892/mco.2013.126
  • Pages: 643-648
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The routine use of postoperative adjuvant chemotherapy in patients with stage II colorectal cancer is not recommended. However, the incidence of tumor recurrence or distant metastasis in these patients is reported to be 25‑35%. The identification of high‑risk patients with stage II colorectal cancer remains difficult. Therefore, the aim of this study was to determine the risk factors that may help identify stage II colorectal cancer patients with unfavorable prognosis. Paraffin‑embedded tissue samples from 109 patients with stage II colorectal cancer following curative operation were analyzed. Thirteen clinicopathological variables and 5 biological markers were assessed using immunohistochemistry, including p53 (tumor suppressor gene), CD10 (tumor invasion marker), CD34 (angiogenic marker), Ki‑67 (cell proliferation index) and CAM 5.2 (marker of lymph node micrometastasis) and investigated for associations with disease‑specific survival. Univariate analysis revealed bowel obstruction, lymph node micrometastasis and lymphatic invasion (P<0.01) to be highly significant factors for determining the 5‑year disease‑specific survival. By contrast, the multivariate analysis revealed lymph node micrometastasis and lymphatic invasion to be independent prognostic factors. Stage II colorectal cancer patients with lymph node micrometastasis and lymphatic invasion may therefore be suitable candidates for adjuvant chemotherapy to improve prognosis.
View Figures
View References

Related Articles

Journal Cover

July 2013
Volume 1 Issue 4

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Ueda, Y., Yasuda, K., Inomata, M., Shiraishi, N., Yokoyama, S., & Kitano, S. (2013). Biological predictors of survival in stage II colorectal cancer. Molecular and Clinical Oncology, 1, 643-648. https://doi.org/10.3892/mco.2013.126
MLA
Ueda, Y., Yasuda, K., Inomata, M., Shiraishi, N., Yokoyama, S., Kitano, S."Biological predictors of survival in stage II colorectal cancer". Molecular and Clinical Oncology 1.4 (2013): 643-648.
Chicago
Ueda, Y., Yasuda, K., Inomata, M., Shiraishi, N., Yokoyama, S., Kitano, S."Biological predictors of survival in stage II colorectal cancer". Molecular and Clinical Oncology 1, no. 4 (2013): 643-648. https://doi.org/10.3892/mco.2013.126